55,674 Shares in Oscar Health, Inc. $OSCR Acquired by Blueshift Asset Management LLC

Blueshift Asset Management LLC bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 55,674 shares of the company’s stock, valued at approximately $1,194,000.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Oscar Health by 3.7% during the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock worth $258,247,000 after purchasing an additional 700,469 shares during the period. T. Rowe Price Investment Management Inc. raised its position in Oscar Health by 4.1% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company’s stock worth $155,043,000 after purchasing an additional 467,301 shares during the last quarter. Thrive Capital Management LLC lifted its holdings in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. American Century Companies Inc. lifted its holdings in Oscar Health by 45.4% during the 2nd quarter. American Century Companies Inc. now owns 2,802,649 shares of the company’s stock worth $60,089,000 after buying an additional 875,388 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Oscar Health in the 1st quarter valued at about $29,684,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of OSCR opened at $16.62 on Tuesday. The firm has a market cap of $4.40 billion, a PE ratio of -14.84 and a beta of 1.88. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.80. The business’s 50 day moving average price is $18.12 and its two-hundred day moving average price is $16.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same quarter in the previous year, the business posted ($0.22) EPS. Oscar Health’s revenue for the quarter was up 23.2% compared to the same quarter last year. Oscar Health has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on OSCR. Wells Fargo & Company lowered their price objective on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, The Goldman Sachs Group initiated coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price objective for the company. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $14.86.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14. Following the completion of the sale, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $7,652,529.96. The trade was a 36.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.